Article Text

Download PDFPDF

Moeller-Hunter glossitis
  1. Kosuke Ishizuka,
  2. Kohta Katayama and
  3. Yoshiyuki Ohira
  1. Department of General Internal Medicine, St Marianna University School of Medicine, Kawasaki, Kanagawa, Japan
  1. Correspondence to Kosuke Ishizuka; e103007c{at}yokohama-cu.ac.jp

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Description

A woman in her 80s presented to our clinic with anaemia. Her medical history and medications were unremarkable. She had no history of alcohol consumption. She had a balanced diet. Vital signs were normal limits. Her tongue was highly atrophic and appeared red and smooth (figure 1). No neurological findings were observed on examination. Laboratory tests revealed megaloblastic anaemia (haemoglobin level of 83 g/dL and mean corpuscular volume of 110 fL). We suspected vitamin B12 deficiency, which was confirmed based on a vitamin B12 level of <50 pg/mL. Upper gastrointestinal endoscopy revealed Helicobacter pylori; therefore, she was diagnosed with vitamin B12 deficiency secondary to atrophic gastritis caused by H. pylori. After successful treatment of H. pylori and initiation of both intramuscular injection and oral administration of vitamin B12, glossitis and anaemia improved within 1 month (figure 2).

Figure 1

Her tongue was highly atrophic and appeared red and smooth.

Figure 2

After successful treatment of Helicobacter pylori and initiation of both intramuscular injection and oral administration of vitamin B12, glossitis and anaemia improved within 1 month.

Glossitis in vitamin B12 deficiency is present in up to 25% cases.1 It is traditionally described as a diffuse and clinically non-specific atrophy of the lingual papillae affecting >50% of the tongue and is classically known as Hunter glossitis or Moeller-Hunter glossitis,2 named after the German surgeon Julius Otto Ludwig Moeller (1819–1887) who described the condition in 18513 and the Scottish physician William Hunter (1861–1937) who described the condition in 1900.4 This glossitis has two stages: inflammatory, with bright red plaques, followed by atrophic, characterised by papillae atrophy affecting >50% of the tongue.2

The causes of vitamin B12 deficiency include vegetarianism, gastric lesions such as those occurring in pernicious anaemia and atrophic gastritis or after gastrectomy, small intestinal lesions, pancreatic insufficiency and use of certain drugs.5 In addition, H. pylori infection is associated with vitamin B12 deficiency, and eradication of H. pylori bacterias normalises serum vitamin B12 levels.6 Previous study has reported H. pylori was detected in 56% of patients with vitamin B12 deficiency, and eradication of H. pylori infection successfully improved anaemia and serum vitamin B12 levels in 40% of infected patients.6 The treatment of vitamin B12 deficiency includes intramuscular vitamin B12 preparations and high-dose oral vitamin B12.5

Learning points

  • Glossitis in vitamin B12 deficiency is present in up to 25% cases. It is traditionally described as a diffuse and clinically non-specific atrophy of the lingual papillae affecting >50% of the tongue and is classically known as Hunter glossitis or Moeller-Hunter glossitis.

  • The causes of vitamin B12 deficiency include vegetarianism, gastric lesions such as those occurring in pernicious anaemia and atrophic gastritis or after gastrectomy, small intestinal lesions, pancreatic insufficiency and use of certain drugs.

  • In addition, Helicobacter pylori infection is associated with vitamin B12 deficiency, and eradication of H. pylori bacterias normalises serum vitamin B12 levels.

Ethics statements

Patient consent for publication

References

Footnotes

  • Contributors KI contributed to write manuscript, patient care and discussion. KK and YO also contributed to discussion and patient care.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.